Wisconsin Alumni Research Foundation

WARF Ventures Portfolio

WARF Venture Startup Portfolio Stats

WARF holds equity in more than 30 of these companies, and more than 50 are located in Wisconsin. Some of these companies have achieved IPO status as publicly traded companies and have been acquired by large, well-established companies, such as Roche, Johnson & Johnson and Hologic.

Interested in learning more about one of these companies? Contact [email protected]


 

ACTIVE STARTUPS

AIQ Solutions home

AIQ Solutions Inc.

Artificial intelligence to evaluate treatment response in complex diseases

Atrility Medical home

Atrility Medical

Device to improve atrial arrhythmia diagnosis

BrainXell

Human neural cells for discovery and therapy

C-Motive Technologies

The world's lightest, most powerful non-rare earth electric motors and non-contact power transfer devices

Co-D Therapeutics home

Co-D Therapeutics Inc.

Innovative cancer drug development

DateChat home

DataChat Inc.

Conversational intelligence platform

Elephas

Developing an imaging platform technology to assess how live tumor cells respond to cancer therapies

Elucent Medical home

Elucent Medical

Innovative surgical navigation tool for tumor excision

FitStack

Shrinks application attack surfaces to optimize cloud container environments and reduce ongoing cloud costs

Flue Gen home

FluGen Inc.

Influenza vaccines

Galilei BioSciences Inc.

Developing sirtuin drugs

Gregor Diagnostics home

Gregor Diagnostics Inc.

Screening and determination of the aggressiveness of prostate cancer

Hubble Therapeutics LLC

Gene therapy for pediatric patients with a retinal blinding disease

Imbed Biosciences

Imbed Biosciences

Multifunctional polymeric nanofilms technology that provides cutting edge solutions in wound healing

Immuto Scientific

Contract research organization providing analytical research services for drug discovery

Infleqtion

Building an ecosystem of quantum technologies & commercial products, driving the industry towards tomorrow

Innervace Logo

Innervace

Regenerative therapy company developing technology that acts as pre-formed, anatomically-inspired, implantable tissue pathways to directly replace lost connections due to brain degeneration or injury

Invenra

Developing versatile drug discovery platforms and optimizing therapies

Isomark

Non-invasive patented platform technology used to monitor health status by measuring and analyzing isotopic biomarkers through exhaled breath

Leo Cancer Care/Asto CT

Stand-up CT scanner and radiotherapy system that reduces the cost of radiotherapy and improves cancer patient outcomes through upright positioning

Lynx Bio home

Lynx Biosciences

Personalized cancer treatments to patients

Madison Vaccines home

Madison Vaccines Inc.

DNA vaccines intended to treat prostate cancer at crucial stages in the disease

OnLume home

OnLume

Medical device for precise fluorescence image-guided surgery

Promiss Diagnostics home

PROMISS Diagnostics Inc.

Globally accessible, non-invasive and precise diagnostic test for ovarian cancer

Pyran

Produces a renewable, sustainable and cost-effective alternative to an oil-based chemical (1,5-pentanediol) found in everyday materials including paint, nylon and other plastics

Quiver Quantitative

Quiver Quantitative

Gathers alternative stock data from across the internet and aggregates it in an easy-to-use web dashboard and mobile app designed for non-professional investors.

Realta Fusion

Realta is developing industrial heat and power from fusion.

Stemina Biomarker Discovery home

Stemina Biomarker Discovery

Metabolomic technologies to understand cell biology in both health and disease

Sustain Holdings home

Stuart Therapeutics

Improved drug delivery using collagen mimetic peptides

Transfur

Harmonizes the veterinary referral management process, making it easy to request, send, and review veterinary medical records.

Ubicept

Ubicept revolutionizes how machines perceive the world by combining next-generation image sensors with advanced computer vision algorithms.


SUCCESSFUL EXITS

Alfa Light home

AlfaLight

Reliable, rugged and efficient laser and electro-optical systems for defense and security applications

CDI home

Cellular Dynamics International

Fully functioning human cells in industrial quantities IPO preceded acquisition Acquired by Fujifilm in 2015

Gala Design logo

Gala Design Inc.

Pharmaceuticals and biotech company focused on pharmaceutical preparations business

NeuWave Medical home

NeuWave Medical

Fast, minimally invasive and highly effective soft tissue ablation system Acquired by Ethicon in 2016

NimbleGen home

NimbleGen Inc.

DNA microarrays, consumables and instruments Acquired by Roche in 2007

Silatronix home

Silatronix Inc.

Organosilicon compounds for energy storage devices, especially electrolytes for lithium-ion batteries

Stratatech home

Stratatech Corporation

Skin regeneration and repair products for therapeutic use Acquired by Mallinckrodt Pharmaceuticals in 2016

Study Blue home

StudyBlue

Online studying platform for high school and college students

Third Wave Technologies home

Third Wave Technologies

Molecular diagnostics for DNA and RNA analysis applications Acquired by Hologic in 2008

Tissue Regeneration Systems home

Tissue Regeneration Systems

Skeletal reconstruction and bone regeneration technology

TomoTherapy home

TomoTherapy

Precise cancer treatment system IPO preceded acquisition Acquired by Accuray in 2011

Virent home

Virent Inc.

Platform that converts soluble biomass-derived sugars into gasoline, diesel and more Acquired by TESORO in 2016

WIN Therapeutics home

WIN Therapeutics

Seeking to discover and develop a bispecific antibody therapuetic for the treatment of neuroblastoma


WARF